Over a dozen phase 3 trials for generic semaglutide are underway in China, setting the stage for one of the world’s largest ...

Greenlane Renewables Inc. ("Greenlane" or the "Company") (TSX: GRN) (FSE: 52G) is pleased to announce the filing of a new patent application for a Linear Nitrogen Rejection Unit (NRU) as part of its ...

Finding the right patent counsel can be challenging, especially as a small company or solo inventor who does not regularly retain intellectual property rights.

Define “exhaustive” by policy, not vibes. Set tiered recall targets (e.g., ≥ 95% estimated recall for Tier-1 matters) and ...

HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark ...

IPWatchdog has learned that Gilbert Hyatt intends to seek en banc review of the Federal Circuit’s prosecution laches doctrine.

“It is essential for the entire industry to get involved and urge the Federal Circuit to rehear this critically important issue en banc.” A Federal Circuit panel recently reached a final decision that ...

I nternal combustion engine development is far from stagnant these days, in spite of the advances in electric powertrains in ...

The USPTO continues to invest heavily in AI capabilities; a new pilot program is designed to assess patent applications for ...

BioNxt Solutions ( ($TSE:BNXT) ) just unveiled an update. BioNxt Solutions Inc. has completed a Track One priority patent filing with the U.S.

The US Supreme Court tossed EcoFactor’s Inc.'s challenge to a Federal Circuit ruling that undid a $20 million ...